Skip to main content
SpringerLink
Log in

Forum to expand biosimilar use launched in US

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Actavis, Amgen, Boehringer Ingelheim, Coherus BioSciences, EMD Serono, Hospira, Merck, Pfizer, Samsung, Sandoz, and Teva

Reference

  • Biosimilars Forum. New Forum Launches to Expand Access to Biosimilar Medicines, Improve Healthcare. Media Release : 5 May 2015. Available from: URL: http://www.biosimilars.org

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Forum to expand biosimilar use launched in US. PharmacoEcon Outcomes News 728, 34 (2015). https://doi.org/10.1007/s40274-015-2154-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2154-2

Search

Navigation